קייליקס
j-c health care ltd - doxorubicin hydrochloride - liposome for infusion - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin - doxorubicin - first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatmnt. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.
זאלטראפ
sanofi - aventis israel ltd - aflibercept 25 mg/ml - concentrate for solution for infusion - zaltrap, in combination with 5-fluorouracil, leucovorin, irinotecan (folfiri), is indicated for adults with metastatic colorectal cancer (mcrc) that is resistant to or has progressed following an oxaliplatin-containing regimen.
גמציטבין "אבווה" 10 מ"ג/1 מ"ל
pharmalogic ltd - gemcitabine as hydrochloride 10 mg - concentrate for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.
מירסרה 250 מק"ג/ 0.3 מ"ל
roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 250 mcg / 0.3 ml - solution for injection - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).
magic torque and platinum plus guidewires
"מדיסון פארמה בע""מ " - מומחה
osmometers, bilirubinometers, spiral plating system, automated colony counters, anaerobic & microphellic condition creator
אגנטק (1987) בע"מ - מומחה - מעבדות ביוכימיות ומיקרו ביולוגיות בבתי חולים
אפורציו iu 1000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 1000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
אפורציו iu 2000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 2000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
אפורציו iu 3000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 3000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
אפורציו iu 4000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 4000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.